Skip to content
  • Home
  • Featured News
  • Services
  • About Us
  • Contact Us
Menu
  • Home
  • Featured News
  • Services
  • About Us
  • Contact Us
Get Free News Alerts
Add FNM To your Feed
  • Home
  • Featured News
  • Services
  • About Us
  • Contact Us
Menu
  • Home
  • Featured News
  • Services
  • About Us
  • Contact Us
Get Free News Alerts
Add FNM To your Feed

Day: January 13, 2020

Growing Demand For Novel Drug Delivery Technologies That Allow Medication To Cross The Blood Brain Barrier

Palm Beach, FL –January 13, 2020 – Reports say that the global drug delivery across brain barrier market size is expected to reach USD $4.6 billion by 2026, according to a new report by Grand View Research, Inc. registering a CAGR of 30.2% over the forecast period. The demand for novel drug delivery technology that […]

CNS Pharmaceuticals Licenses Breakthrough Technology from MD Anderson, Doubling its Drug Pipeline

Houston, TX – January 13, 2020 – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced it has entered into a licensing agreement with MD Anderson to investigate WP1244, an entirely new class of DNA-binding agents designed to cross the […]

Sign Up For FREE Stock Alerts From
Be the First To Know When Emerging Public Companies Issue Breaking News!
SIGN UP HERE
  • Terms of Service
  • Privacy Policy
  • Disclaimer
  • Sitemap
Menu
  • Terms of Service
  • Privacy Policy
  • Disclaimer
  • Sitemap

FINANCIALNEWSMEDIA.COM (FNM) IS A THIRD PARTY PUBLISHER AND NEWS DISSEMINATION SOLUTIONS PROVIDER OF MULTIMEDIA PLATFORMS THAT ENABLE OFFICERS & DIRECTORS, CORPORATE COMMUNICATORS, PUBLIC RELATIONS AND INVESTOR RELATIONS OFFICERS TO LEVERAGE CONTENT TO ENGAGE WITH ALL THEIR KEY AUDIENCES. ANY IDEAS AND OPINIONS PRESENTED IN ANY FNM NEWS ALERTS, VIDEO CLIPS, PRESS RELEASES, RSS FEEDS OR SOCIAL NETWORK POSTS ARE FOR INFORMATIONAL PURPOSES ONLY, AND DO NOT REFLECT THE OPINIONS OF FNM OR ANY OF ITS AFFILIATES, SUBSIDIARIES OR PARTNERS. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT CONTAINED HEREIN BE INTERPRETED TO REPRESENT TRADING OR INVESTMENT ADVICE. ALL VIEWERS AGREE THAT UNDER NO CIRCUMSTANCES WILL FNM, ITS SUBSIDIARIES, PARTNERS, OFFICERS, EMPLOYEES, AFFILIATES, OR AGENTS BE HELD LIABLE FOR ANY LOSS OR DAMAGE CAUSED BY YOUR RELIANCE ON INFORMATION CONTAINED ON THIS OR ANY AFFILIATED WEBSITE.

Copyright 2025 Financial News Media © All rights Reserved.